When tumor burden met maximum defined endpoints allowed by the IACUC (end point), the levels of PD-L1 were not significantly different in tumors of PyMT mice treated with LG268 vs. control fed mice (Fig. 8d). The gene discussed is CD274; the disease is neoplasm.